Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Horizon Pharma Public Limited Company (HZNP)

20.57 -0.03 (-0.15%)

08-17 16:00

Open:

20.63

Pre. Close:

20.6

High:

20.63

Low:

20.175

Volume:

1,451,907

Market Cap:

3428M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

20.688 - 20.803

20.803 - 20.896

Low:

19.814 - 19.977

19.977 - 20.109

Close:

20.327 - 20.572

20.572 - 20.771

Technical analysis  (as of: 2018-08-17 4:26:47 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 24.82     One year: 28.99

Support:

Support1: 18.43    Support2: 16.68

Resistance:

Resistance1: 21.25    Resistance2: 24.82

Pivot:

19.30

Moving Averages:

MA(5): 20.49     MA(20): 18.86

MA(100): 16.20     MA(250): 14.95

MACD:

MACD(12,26): 0.93     Signal(12,26,9): 0.77

%K %D:

%K(14,3): 76.58     %D(3): 77.53

RSI:

RSI(14): 68.58

52-Week:

High: 21.25  Low: 11.17  Change(%): 56.2

Average Vol(K):

3-Month: 171773  10-Days 212529

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
HZNP has closed below upper band by 27.0%. Bollinger Bands are 182.3% wider than normal. The large width of the bands suggest high volatility as compared to HZNP's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

2018-08-08T14:43:05-04:00
Horizon Pharma plc (HZNP) CEO Timothy Walbert on Q2 2018 Results - Earnings Call Transcript

2018-08-08T08:22:20-04:00
Horizon Pharma plc 2018 Q2 - Results - Earnings Call Slides

2018-08-08T07:02:43-04:00
Horizon Pharma beats by $0.17, beats on revenue

2018-08-08T07:00:00-04:00
Horizon Pharma plc Reports Record Quarterly Net Sales for Orphan and Rheumatology Segment; Increases Full-Year 2018 Adjusted EBITDA Guidance; Implements New Company Operating Structure to Enhance Focus on Rare Diseases

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

166.63

Shares Float (M)

164.79

% Held by Insiders

1.10

% Held by Institutions

83.90

Shares Short (K)

10277

Shares Short Prior Month (K)

Stock Financials

EPS

1.060

EPS Est. Current Year

1.070

EPS Est. Next Year

1.250

EPS Est. Next Quarter

0.230

Forward EPS

1.769

Book Value (p.s.)

4.060

PEG Ratio

0.70

Profit Margin

-28.02

Operating Margin

-9.38

Return on Assets (ttm)

-7.4

Return on Equity (ttm)

-31.8

Qtrly Rev. Growth

1.4

Gross Profit (p.s.)

0.877

Sales Per Share

EBITDA (p.s.)

0.266

Qtrly Earnings Growth

Operating Cash Flow (M)

194.59

Levered Free Cash Flow (M)

364.98

Valuation

P/E

19.41

P/E Growth Ratio

P/BV

5.07

P/S

524709856.00

P/CF

17.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.